Ignite Creation Date:
2024-05-05 @ 11:33 AM
Last Modification Date:
2024-10-26 @ 9:09 AM
Study NCT ID:
NCT00073983
Status:
COMPLETED
Last Update Posted:
2012-03-12
First Post:
2003-12-10
Brief Title:
Gemcitabine and Docetaxel in Treating Patients With Recurrent Osteosarcoma Closed to Accrual as of 122106 or Ewings Sarcoma or Unresectable or Locally Recurrent Chondrosarcoma
Sponsor:
Organization:
Sarcoma Alliance for Research through Collaboration
Study Design
Study Type:
INTERVENTIONAL
Expanded Access Type Individual:
None
Expanded Access Type Intermediate:
None
Expanded Access Type Treatment:
None
Patient Registry:
None
Target Duration:
None
Design Allocation:
Design Intervention Model:
Design Intervention Model Description:
Design Masking Description:
Bio Spec Retention:
None
Bio Spec Description:
None
Enrollment Count:
54
Enrollment Type:
ACTUAL
Design Primary Purpose:
Design Masking:
Phases:
| Name |
|---|
| PHASE2 |
Observational Models:
Time Perspective List:
Who Masked List: